Corvex Management’s Arbutus Biopharma ABUS Stock Holding History

Corvex Management’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-66,900	Closed	-$793K	–	39
2015 Q2	$793K	Sell	66,900 -65,000	-49%	-$989K	0.01%	40
2015 Q1	$2.3M	Buy	+131,900	New	+$2.7M	0.03%	38

Other funds holding ABUS

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Corvex Management's ABUS Position: Q3 2015 in Review

Corvex Management sold out of Arbutus Biopharma (ABUS) in Q3 2015, closing a stake of 66,900 shares — an estimated $793K sold.

Corvex Management first reported a position in ABUS in Q1 2015 and held it in 2 quarters. The position peaked at $2.3M in Q1 2015. 55 funds tracked by Wall St. Rank hold ABUS as of Q3 2015.

Corvex Management reported no remaining Arbutus Biopharma position as of Q3 2015 after selling out during the quarter.
Corvex Management sold 66,900 Arbutus Biopharma shares in Q3 2015, an estimated $793K.
Corvex Management first reported a position in Arbutus Biopharma in Q1 2015 and held it in 2 quarters.
Corvex Management's Arbutus Biopharma position peaked at $2.3M in Q1 2015.
55 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2015.

Based on Corvex Management's 13F filing for Q3 2015, filed 16 Nov 2015.